Cello Health PLC Additional Block Listing of Ordinary Shares (5348V)
07 Agosto 2020 - 1:52PM
UK Regulatory
TIDMCLL
RNS Number : 5348V
Cello Health PLC
07 August 2020
7 August 2020
Cello Health plc
("Cello" or the "Company")
Additional Block Listing of Ordinary Shares
Following the Court Hearing held earlier today in connection
with the cash acquisition of Cello Health plc by Pharma Value
Demonstration Bidco Limited, the Company announces that an
application has been made for a block admission for 2,421,000 new
ordinary shares of 10p each ("Ordinary Shares") to be admitted to
trading on AIM.
These new Ordinary Shares will be issued and allotted pursuant
to the exercise of existing options under the Company's Performance
Share Plan 2010, the HM Revenue & Customs Approved Company
Share Option Plan and its Unapproved Share Option Plan. New
Ordinary Shares, when issued, will rank pari passu with the
existing Ordinary Shares of the Company.
Admission of the new Ordinary Shares is expected to occur on 10
August 2020.
Enquires
Cello Health 020 7812 8460
Mark Scott, Chief Executive
Mark Bentley, Group Finance
Director
Cenkos Securities 020 7397 8900
Giles Balleny
Harry Hargreaves
Buchanan 020 7466 5000
Mark Court
Jamie Hooper
Sophie Wills
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
ALSEAFPXELNEEFA
(END) Dow Jones Newswires
August 07, 2020 07:52 ET (11:52 GMT)
Grafico Azioni Cello Health (LSE:CLL)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Cello Health (LSE:CLL)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Cello Health Plc (Borsa di Londra): 0 articoli recenti
Più Cello Health Plc Articoli Notizie